Last edition
News about "oral therapy "
BioCryst Announces Approval of ORLADEYO from Brazilian Health Regulatory Agency
BioCryst Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults.
Oral Therapy | 20/04/2024 | By Aishwarya | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members